Cytokeratin expression profiling in gastric carcinoma: Clinicopathologic significance and comparison with tumor-associated molecules

Pathobiology

Volumn 79, Issue 3, 2012, Pages 154-161

  Takami, Hokuto ^a   Sentani, Kazuhiro ^a   Matsuda, Miho ^a   Oue, Naohide ^a   Sakamoto, Naoya ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cytokeratin; Gastric cancer; Mucin phenotype; Tumor associated molecules

Indexed keywords

BETA CATENIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 6; PROTEIN P53; TRANSCRIPTION FACTOR CDX2; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; TISSUE MICROARRAY; UNDIFFERENTIATED CARCINOMA;

HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; KERATINS; MUCIN 5AC; MUCIN-2; MUCIN-6; MUCINS; NEPRILYSIN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856207373     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000335694     Document Type: Article

References (32)

1. Carneiro F, Sobrinho-Simoes M: Metastatic pattern of gastric carcinoma. Hum Pathol 1996; 27: 213-214.
2. Yasui W, Oue N, Kitadai Y, Nakayama H: Recent advances in molecular pathobiology of gastric carcinoma; in Kaminishi M, Takubo K, Mafune K (eds): The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis and Therapy. Tokyo, Springer, 2005, pp 51-71.
3. Tatematsu M, Tsukamoto T, Inada K: Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003; 94: 135-141. (Pubitemid 36575871)
4. Yasui W, Sentani K, Motoshita J, Nakayama H: Molecular pathobiology of gastric cancer. Scand J Surg 2006; 95: 225-231. (Pubitemid 46089255)
5. Chu PG, Weiss LM: Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403-439. (Pubitemid 34535443)
6. Chu P, Wu E, Weiss LM: Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962-972.
7. Moll R: Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 1994; 9: 63-69. (Pubitemid 24225515)
8. Moll R, Lowe A, Laufer J, Franke WW: Cytokeratin in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-447.
9. Schwerer MJ, Baczako K: Expression of cytokeratins typical for ductal and squamous differentiation in the human stomach: an immunohistochemical study of normal foveolar epithelium, Helicobacter pylori gastritis and intestinal metaplasia. Histopathology 1996; 29: 131-137. (Pubitemid 26264437)
10. Ramaekers F, van Niekerk C, Poels L, Schaafs ma E, Huijsmans A, Robben H, Schaart G, Vooijs P: Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990; 136: 641-655. (Pubitemid 20105931)
11. Tot T: Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002; 38: 758-763. (Pubitemid 34280319)
12. Park SY, Kim HS, Hong EK, Kim WH: Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 2002; 33: 1078-1085. (Pubitemid 35416704)
13. Moll R: Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 1998; 31: 205-262.
14. Wauters CC, Smedts F, Gerrits LG, Bosman FT, Ramaekers FC: Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995; 26: 852-855.
15. Kirchner T, Muller S, Hattori T, Mukaisyo K, Papadopoulos T, Brabletz T, Jung A: Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin- expression in gastritis. Virchows Arch 2001; 439: 512-522. (Pubitemid 32930177)
16. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Gramlich TL: The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 2001; 38: 307-311. (Pubitemid 34225024)
17. Kim MA, Lee HS, Yang HK, Kim WH: Cytokeratin expression profile in gastric carcinomas. Hum Pathol 2004; 35: 576-581. (Pubitemid 38656942)
18. Shen B, Ormsby AH, Shen C, Dumot JA, Shao YW, Bevins CL, Gramlich TL: Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction. Cancer 2002; 94: 820-831. (Pubitemid 34132313)
19. Gurbuz Y, Kose N: Cytokeratin expression patterns of gastric carcinomas according to Lauren and Goseki classification. Appl Immunohistochem Mol Morphol 2006; 14: 303-308. (Pubitemid 44319056)
20. Lee MJ, Lee HS, Kim WH, Choi Y, Yang M: Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003; 16: 403-410. (Pubitemid 36618459)
21. Xue L, Zhang X, Li Y, Yang H, Li X, Mi J, Wang H, Wang J, Yan X: Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach. Hum Pathol 2011; 42: 594-601.
22. Sobin LH, Wittekind CH (eds): TNM Classification Of Malignant Tumors, ed 6. New York, Wiley, 2002, pp 65-68.
23. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma, 3rd English edition. Gastric Cancer 2011; 14: 101-112.
24. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M: Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 2003; 129: 727-734. (Pubitemid 38002304)
25. Sauter G, Mirlacher M: Tissue microarrays for predictive molecular pathology. J Clin Pathol 2002; 55: 575-576.
26. Sentani K, Oue N, Tashiro T, Sakamoto N, Nishisaka T, Fukuhara T, Taniyama K, Matsuura H, Arihiro K, Ochiai A, Yasui W: Immunohistochemical staining of reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am J Surg Pathol 2008; 32: 1182-1189.
27. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001; 158: 1245-1151.
28. Lee HS, Cho SB, Lee HE, Kim MA, Kim JH, Park do J, Kim JH, Yang HK, Lee BL, Kim WH: Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res 2007; 13: 4154-4163. (Pubitemid 47105978)
29. Gulmann C, Counihan I, Grace A, Patchett S, Leen E, Leader M, Kay E: Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas. Histopathology 2003; 43: 453-461. (Pubitemid 37445236)
30. Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A: Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma. Virchows Arch 2002; 440: 304-310. (Pubitemid 34230736)
31. Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M: MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch 2004; 444: 224-230. (Pubitemid 38446433)
32. Chan CW, Wong NA, Liu Y, Bicknell D, Turley H, Hollins L, Miller CJ, Wilding JL, Bodmer WF: Gastrointestinal differentiation marker cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci USA 2009; 106: 1936-1941.